UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

European journal of cancer (1990), 2019-09, Vol.118, p.35-40

2019

Volltextzugriff (PDF)

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact

European journal of cancer (1990), 2016-12, Vol.69, p.158-165

2016

Volltextzugriff (PDF)

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

European journal of cancer (1990), 2019-03, Vol.110, p.62-70

2019

Volltextzugriff (PDF)

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2019-12, Vol.30 (12), p.1856-1883

2019

Volltextzugriff (PDF)

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study

Annals of oncology, 2012-07, Vol.23 (7), p.1832-1837

2012

Volltextzugriff (PDF)

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

Oral oncology, 2009-07, Vol.45 (7), p.574-578

2009

Volltextzugriff (PDF)

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

European journal of cancer (1990), 2018-07, Vol.97, p.7-15

2018

Volltextzugriff (PDF)

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

Annals of oncology, 2022-07, Vol.33 (7), p.674-684

2022

Volltextzugriff (PDF)

Occupation and cancer of the larynx: a systematic review and meta-analysis

European archives of oto-rhino-laryngology, 2016-01, Vol.273 (1), p.9-20

2016

Volltextzugriff (PDF)

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)

European journal of cancer (1990), 2008-11, Vol.44 (17), p.2542-2545

2008

Volltextzugriff (PDF)

Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer

Annals of oncology, 2011-11, Vol.22 (11), p.2495-2500

2011

Volltextzugriff (PDF)

Prediction of TP53 Status for Primary Cisplatin, Fluorouracil, and Leucovorin Chemotherapy in Ethmoid Sinus Intestinal-Type Adenocarcinoma

Journal of clinical oncology, 2004-12, Vol.22 (24), p.4901-4906

2004

Volltextzugriff (PDF)

Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients

Annals of oncology, 2011-08, Vol.22 (8), p.1886-1893

2011

Volltextzugriff (PDF)

Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options

Annals of oncology, 2008-09, Vol.19 (suppl-7), p.vii200-vii203

2008

Volltextzugriff (PDF)

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients

Baillière's best practice & research. Clinical endocrinology & metabolism, 2017-06, Vol.31 (3), p.349-361

2017

Volltextzugriff (PDF)

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2017-11, Vol.28 (11), p.2820-2826

2017

Volltextzugriff (PDF)

Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up

ESMO open, 2022-12, Vol.7 (6), p.100602-100602, Article 100602

2022

Volltextzugriff (PDF)

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding

Annals of oncology, 2017-09, Vol.28 (9), p.2321-2322

2017

Volltextzugriff (PDF)

Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cells

Annals of oncology, 2018-07, Vol.29 (7), p.1599

2018

Volltextzugriff (PDF)

Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer

Annals of oncology, 2003-03, Vol.14 (3), p.367-372

2003

Volltextzugriff (PDF)

Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib

Endocrine, 2021-09, Vol.73 (3), p.641-647

2021

Volltextzugriff (PDF)

Head and neck cancer

Annals of oncology, 2004-01, Vol.15 (suppl-4), p.iv267-iv273

2004

Volltextzugriff (PDF)

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients

Annals of oncology, 2007-03, Vol.18 (3), p.601-602

2007

Volltextzugriff (PDF)

Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma

Annals of oncology, 2017-10, Vol.28, p.vi73-vi73

2017

Volltextzugriff (PDF)

A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland

Annals of oncology, 2003-08, Vol.14 (8), p.1327-1328

2003

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact

Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

Occupation and cancer of the larynx: a systematic review and meta-analysis

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)

Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer

Prediction of TP53 Status for Primary Cisplatin, Fluorouracil, and Leucovorin Chemotherapy in Ethmoid Sinus Intestinal-Type Adenocarcinoma

Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients

Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients

A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

Salivary gland cancer: ESMO–European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up

Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding

Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cells

Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer

Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib

Head and neck cancer

Previously irradiated areas spared from skin toxicity induced by cetuximab in six patients: implications for the administration of EGFR inhibitors in previously irradiated patients

Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma

A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland

Suchergebnisse filtern